Primary Melanoma Tumor Infiltrating Lymphocytes (TILs) as a Predictor for Immunotherapy Response

被引：0
|
作者：
Harter, Cameron A. [1 ]
Dalman, Jessie M. [1 ]
Elhossiny, Ahmed [1 ]
Bresler, Scott C. [2 ]
Lao, Christopher [3 ]
Angeles, Christina V. [4 ]
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Univ Michigan, Pathol, Ann Arbor, MI USA
[3] Univ Michigan, Internal Med, Ann Arbor, MI USA
[4] Univ Michigan, Surg, Ann Arbor, MI USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E226
引用
收藏
页码：S237 / S238
页数：2
相关论文
共 50 条
  • [1] Tumor Infiltrating Lymphocytes (TILs) and Tertiary Lymphoid Structures (TLS) as a Predictor of Immunotherapy Response in Endometrial Cancer
    Keske, Aysenur
    Lozar, Taja
    Fitzpatrick, Megan
    LABORATORY INVESTIGATION, 2023, 103 (03) : S929 - S929
  • [2] Tumor-infiltrating lymphocytes for melanoma immunotherapy
    Kepp, Oliver
    Liu, Peng
    Zitvogel, Laurence
    Kroemer, Guido
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [3] Expansion and Characterization of Human Melanoma Tumor-Infiltrating Lymphocytes (TILs)
    Nguyen, Linh T.
    Yen, Pei Hua
    Nie, Jessica
    Liadis, Nicole
    Ghazarian, Danny
    Al-Habeeb, Ayman
    Easson, Alexandra
    Leong, Wey
    Lipa, Joan
    McCready, David
    Reedijk, Michael
    Hogg, David
    Joshua, Anthony M.
    Quirt, Ian
    Messner, Hans
    Shaw, Patricia
    Crump, Michael
    Sharon, Eran
    Ohashi, Pamela S.
    PLOS ONE, 2010, 5 (11):
  • [4] Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients
    Tas, Faruk
    Erturk, Kayhan
    CANCER INVESTIGATION, 2017, 35 (08) : 501 - 505
  • [5] Correlation of primary melanoma tumour mitotic count and tumour infiltrating lymphocytes with response to immunotherapy
    Gard, Grace
    Yau, Wing Hing
    Haydon, Andrew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 189 - 189
  • [6] Tumor-infiltrating lymphocytes in primary uveal melanoma
    Gezgin, G.
    Visser, M.
    van der Burg, S. H.
    Verdegaal, E. M.
    Jager, M. J.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 46 - 47
  • [7] Tumour-infiltrating lymphocytes (TILs) as a predictor of response to neadjuvant chemotherapy in breast cancer
    Hernandez Leon, L.
    Tapia Melendo, G.
    Castello Fernandez, E.
    Sanhueza, T. V.
    Marginet Flinch, R.
    Martin Cespedes, M.
    Quiroga Garcia, V.
    Margeli Vila, M.
    VIRCHOWS ARCHIV, 2018, 473 : S57 - S57
  • [8] ASO Visual Abstract: Is There a Relationship Between Tumor-Infiltrating Lymphocytes (TILs) and Regression in Melanoma?
    Steven Morrison
    Gang Han
    Faith Elenwa
    John Vetto
    Graham Fowler
    Stanley P. Leong
    Mohammed Kashani-Sabet
    Barbara Pockaj
    Heidi E. Kosiorek
    Jonathan S. Zager
    Jane L. Messina
    Nicola Mozzillo
    Schlomo Schneebaum
    Dale Han
    Annals of Surgical Oncology, 2022, 29 : 2869 - 2870
  • [9] Prevalence of PDL1 and tumor infiltrating lymphocytes (TILs) in primary and metastatic TNBC
    Li, Yijin
    Chang, Ching-Wei
    Tran, David
    Denker, Mitchell
    Hegde, Priti
    Molinero, Luciana
    CANCER RESEARCH, 2018, 78 (04)
  • [10] Upgrading the Diagnostic Assessment in Primary Pulmonary Carcinoids: The Tumor-infiltrating Lymphocytes (TILs)
    Roncati, Luca
    Manenti, Antonio
    Piscioli, Francesco
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (12): : 1288 - 1289
12345